Medicine Description debosteobone 70mg
Debosteobone 70 mg tablets is a medication that combines alendronate sodium and cholecalciferol to combat osteoporosis. Alendronate, a bisphosphonate, works by inhibiting osteoclast-mediated bone resorption, leading to increased bone mineral density and a reduction in the risk of fractures. Cholecalciferol, a form of vitamin D, enhances calcium absorption in the intestines and helps maintain adequate serum calcium and phosphate levels, which are essential for normal bone mineralization. Together, these components work synergistically to improve bone strength and reduce the likelihood of osteoporosis-related fractures.
Indications and Uses of Debosteobone 70 mg tablets
- Management of osteoporosis in postmenopausal women
- Prevention of osteoporosis in individuals at high risk of fractures
- Increased bone mass in men with osteoporosis
Side Effects of Debosteobone 70 mg tablets
- Gastrointestinal discomfort
- Esophageal irritation or ulcer
- Musculoskeletal pain
- Hypocalcemia
- Rarely, osteonecrosis of the jaw
Storage and Handling
Store Debosteobone 70 mg tablets at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
Patient Advice and Precautions
It is crucial to take this medication in the morning, upon awakening, with a full glass of water, and to remain upright for at least 30 minutes afterward to minimize gastrointestinal side effects. Regular dental check-ups are recommended due to the risk of osteonecrosis of the jaw. Adhering to a balanced diet rich in calcium and vitamin D, along with weight-bearing exercise, can enhance bone health.